On March 28, 2024, Alliance Defending Freedom announced that it has filed an exempt solicitation statement with Securities and Exchange Commission, urging the shareholders of urging the shareholders of Merck & Co Inc to vote for a shareholder proposal regarding report on respecting workforce civil liberties, at the 2024 annual meeting of shareholders.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
131.2 USD | +0.37% | +4.31% | +20.34% |
Apr. 26 | Wolfe Research Adjusts Price Target on Merck & Company to $151 From $141 | MT |
Apr. 26 | Morgan Stanley Adjusts Merck & Co.'s Price Target to $132 From $128 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.34% | 332B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B | |
-11.77% | 144B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Alliance Defending Freedom Files Exempt Solicitation Statement with Securities and Exchange Commission